DYADIC INTERNATIONAL INC Investment Income, Interest
DYADIC INTERNATIONAL INC (DYAI) reported Investment Income, Interest of $39.70 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-12
- DYADIC INTERNATIONAL INC investment income, interest for the quarter ending 2026-06-30 was $39.70K, a 19.18% decline year-over-year.
- DYADIC INTERNATIONAL INC investment income, interest for the quarter ending 2026-03-31 was $57.19K, a 35.35% decline year-over-year.
- DYADIC INTERNATIONAL INC investment income, interest for the quarter ending 2025-12-31 was $83.03K, a 19.97% decline year-over-year.
- DYADIC INTERNATIONAL INC investment income, interest for the quarter ending 2025-09-30 was $63.47K, a 50.16% decline year-over-year.
- DYADIC INTERNATIONAL INC investment income, interest for fiscal 2025 was $284.08K, a 37.84% decline from fiscal 2024.
- DYADIC INTERNATIONAL INC investment income, interest for fiscal 2024 was $456.99K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $39.70K 10-Q · filed 2026-08-12 | $96.90K 10-Q · filed 2026-08-12 | $179.93K derived: sum of 3 quarters · filed 2026-08-12 | $243.40K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $57.19K 10-Q · filed 2026-05-13 | $140.22K derived: sum of 2 quarters · filed 2026-05-13 | $203.69K derived: sum of 3 quarters · filed 2026-05-13 | $252.82K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $83.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $146.50K derived: sum of 2 quarters · filed 2026-03-25 | $195.63K derived: sum of 3 quarters · filed 2026-08-12 | $284.08K 10-K · filed 2026-03-25 |
| 2025-09-30 | $63.47K 10-Q · filed 2025-11-12 | $112.59K derived: sum of 2 quarters · filed 2026-08-12 | $201.05K 10-Q · filed 2025-11-12 | $304.80K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $49.13K 10-Q · filed 2026-08-12 | $137.59K 10-Q · filed 2026-08-12 | $241.33K derived: sum of 3 quarters · filed 2026-08-12 | $368.66K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $88.46K 10-Q · filed 2026-05-13 | $192.21K derived: sum of 2 quarters · filed 2026-05-13 | $319.54K derived: sum of 3 quarters · filed 2026-05-13 | $458.01K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $103.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $231.08K derived: sum of 2 quarters · filed 2026-03-25 | $369.55K derived: sum of 3 quarters · filed 2026-03-25 | $456.99K 10-K · filed 2026-03-25 |
| 2024-09-30 | $127.33K 10-Q · filed 2025-11-12 | $265.80K derived: sum of 2 quarters · filed 2025-11-12 | $353.25K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $138.47K 10-Q · filed 2025-08-13 | $225.91K 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |